cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Puma Biotechnology Inc
18 own
49 watching
Current Price
$4.76
$0.24
(5.31%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
221.86M
52-Week High
52-Week High
5.16
52-Week Low
52-Week Low
1.6
Average Volume
Average Volume
0.47M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization221.86M
icon52-Week High5.16
icon52-Week Low1.6
iconAverage Volume0.47M
iconDividend Yield--
iconP/E Ratio--
What does the Puma Biotechnology Inc do?
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to improve cancer care. Its drug candidates include PB272 (neratinib (oral)) for the treatment of early stage breast cancer, metastatic breast cancer, non-small cell lung cancer, HER2 mutation-positive solid tumors, and HER2-mutated non-amplified breast cancer; and PB272 (neratinib (intravenous)). The company also develops PB357, an orally administered agent that is an irreversible tyrosine kinase inhibitor that blocks signal transduction through the epidermal growth factor receptors, HER1, HER2, and HER4. It has a license agreement with Pfizer, Inc. for the development, manufacture, and commercialization of PB272 neratinib (oral), PB272 neratinib (intravenous), PB357, and certain related compounds. Puma Biotechnology, Inc. was founded in 2010 and is headquartered in Los Angeles, California.
Read More
How much money does Puma Biotechnology Inc make?
News & Events about Puma Biotechnology Inc.
Business Wire
30days ago
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, provided an update to the corporate presentation that its Chief Executive Officer and President, Alan H. Auerbach, will refer to in meetings beginning Monday, January 9, 2023. The updated presentation includes, among other...
Benzinga
3 months ago
On Tuesday, shares of Puma Biotechnology, Inc. (NASDAQ: PBYI) experienced volatile short activity. After the activity, the stock price went up +3.99% to $3.26. The overall sentiment for PBYI has been Bullish. read more...
Business Wire
3 months ago
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, presented updated findings from the Phase II SUMMIT basket trial of neratinib for EGFR exon 18-mutant non-small cell lung cancer (NSCLC) patients at the EORTC/NCI/AACR Molecular Targets and Cancer Therapeutics Symposium that is...
Business Wire
5 months ago
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced the presentation of updated findings from the Phase II SUMMIT basket trial of neratinib for HER2 (ERBB2)-mutant, metastatic cervical cancer at the 2022 European Society for Medical Oncology (ESMO) Congress, currently...
Business Wire
8 months ago
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, presented final results from the Phase II SUMMIT basket trial, assessing the efficacy of neratinib in treatment-refractory patients with metastatic biliary tract cancers with somatic HER2 mutations at the 2022 American Society of...
Frequently Asked Questions
Frequently Asked Questions
What is Puma Biotechnology Inc share price today?
plus_minus_icon
Can Indians buy Puma Biotechnology Inc shares?
plus_minus_icon
How can I buy Puma Biotechnology Inc shares from India?
plus_minus_icon
Can Fractional shares of Puma Biotechnology Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Puma Biotechnology Inc stocks?
plus_minus_icon
What is today’s traded volume of Puma Biotechnology Inc?
plus_minus_icon
What is today’s market capitalisation of Puma Biotechnology Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Puma Biotechnology Inc?
plus_minus_icon
What percentage is Puma Biotechnology Inc down from its 52-Week High?
plus_minus_icon
What percentage is Puma Biotechnology Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$4.76
$0.24
(5.31%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00